Discovery of AZD2624: a potent and selective NK3 antagonist to test the NK3 hypothesis in schizophrenia - Simpson, T R; Gadient, R; Li, Y
Abstracts of Papers, 239th ACS National Meeting. March 21–25, 2010. San Francisco, CA